The current epidemic situation of coronavirus disease 2019 (COVID-19) still remained severe. As the National Clinical Research Center for Infectious Diseases, the First Affiliated Hospital of Zhejiang University School of Medicine is the primary medical care center for COVID-19 in Zhejiang province. Based on the present expert consensus carried out by National Health Commission and National Administration of Traditional Chinese Medicine, our team summarized and established an effective treatment strategy centered on “Four-Anti and Two-Balance” for clinical practice.
The “Four-Anti and Two-Balance” strategy included antivirus, anti-shock, anti-hyoxemia, anti-secondary infection, and maintaining of water, electrolyte and acid base balance and microecological balance. Meanwhile, integrated multidisciplinary personalized treatment was recommended to improve therapeutic effect. The importance of early viralogical detection, dynamic monitoring of inflammatory indexes and chest radiograph was emphasized in clinical decision-making.
Sputum was observed with the highest positive rate of RT-PCR results. Viral nucleic acids could be detected in 10%patients’ blood samples at acute period and 50%of patients had positive RT-PCR results in their feces. We also isolated alive viral strains from feces, indicating potential infectiousness of feces.Dynamic cytokine detection was necessary to timely identifying cytokine storms and application of artificial liver blood purification system.
human FcRn, His tag |
E410A15-10 |
EnoGene |
10μg |
EUR 694 |
anti- FcRn-Specific antibody |
FNab03063 |
FN Test |
100µg |
EUR 585 |
|
Description: Antibody raised against FcRn-Specific |
FcRn-Specific Blocking Peptide |
DF12607-BP |
Affbiotech |
1mg |
EUR 195 |
FcRn & B2M Heterodimer Recombinant Protein |
92-311 |
ProSci |
0.05 mg |
EUR 542.75 |
Description: FcRn complex consist of two subunits: IgG receptor FcRn large subunit p51(alpha chain) and Beta-2-microglobulin(Beta chain). The complexes is similar in structure to MHC class I-like heterodimer. Beta-2-microglobulin involved in the presentation of peptide antigens to the immune system. FcRn binds to the Fc region of monomeric immunoglobulins gamma, mediates the uptake of IgG from milk,Possible role in transfer of immunoglobulin G from mother to fetus. A principal component of antibody transport is the neonatal receptor for the Fc portion of immunoglobulin, a heterodimer of a MHC-1 alpha-chain homolog ( FcRn ) and beta-2-microglobulin ( B2M ). |
FcRn & B2M Heterodimer Recombinant Protein |
92-590 |
ProSci |
0.05 mg |
EUR 401 |
Description: FcRn complex consist of two subunits: IgG receptor FcRn large subunit p51(alpha chain) and Beta-2-microglobulin(Beta chain). The complexes is similar in structure to MHC class I-like heterodimer. Beta-2-microglobulin involved in the presentation of peptide antigens to the immune system. FcRn binds to the Fc region of monomeric immunoglobulins gamma, mediates the uptake of IgG from milk,Possible role in transfer of immunoglobulin G from mother to fetus. A principal component of antibody transport is the neonatal receptor for the Fc portion of immunoglobulin, a heterodimer of a MHC-1 alpha-chain homolog ( FcRn ) and beta-2-microglobulin ( B2M ). |
ELISA kit for Mouse FCRN/FCGRT |
EK5682 |
SAB |
96 tests |
EUR 553 |
Description: Enzyme-linked immunosorbent assay kit for quantification of Mouse FCRN/FCGRT in samples from serum, plasma, tissue homogenates and other biological fluids. |
Recombinant Human FcRn & B2M Heterodimer (C-6His) |
CI01-10ug |
Novoprotein |
10ug |
EUR 156 |
Description: Lyophilized from a 0.2 μm filtered solution of 50mM HEPES,150mM Nacl,pH7.4. |
Recombinant Human FcRn & B2M Heterodimer (C-6His) |
CI01-1mg |
Novoprotein |
1mg |
EUR 2283 |
Description: Lyophilized from a 0.2 μm filtered solution of 50mM HEPES,150mM Nacl,pH7.4. |
Recombinant Human FcRn & B2M Heterodimer (C-6His) |
CI01-500ug |
Novoprotein |
500ug |
EUR 1613 |
Description: Lyophilized from a 0.2 μm filtered solution of 50mM HEPES,150mM Nacl,pH7.4. |
Recombinant Human FcRn & B2M Heterodimer (C-6His) |
CI01-50ug |
Novoprotein |
50ug |
EUR 369 |
Description: Lyophilized from a 0.2 μm filtered solution of 50mM HEPES,150mM Nacl,pH7.4. |
Recombinant Mouse FcRn & B2M Heterodimer (C-6His) |
CK96-10ug |
Novoprotein |
10ug |
EUR 126 |
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
Recombinant Mouse FcRn & B2M Heterodimer (C-6His) |
CK96-1mg |
Novoprotein |
1mg |
EUR 1877 |
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
Recombinant Mouse FcRn & B2M Heterodimer (C-6His) |
CK96-500ug |
Novoprotein |
500ug |
EUR 1328 |
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
Recombinant Mouse FcRn & B2M Heterodimer (C-6His) |
CK96-50ug |
Novoprotein |
50ug |
EUR 232 |
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
Rabbit Anti-Human FcRn/b2M Protein (FCGRT/FcRn 1-297aa+B2M 1-119aa heterodimer) IgG, Aff pure |
FCRN11-A |
Alpha Diagnostics |
100 ug |
EUR 347 |
Human IgG receptor FcRn large subunit p51 (FCGRT) |
1-CSB-YP008545HU |
Cusabio |
-
EUR 430.00
-
EUR 234.00
-
EUR 1508.00
-
EUR 642.00
-
EUR 1009.00
-
EUR 291.00
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Human IgG receptor FcRn large subunit p51(FCGRT),partial expressed in Yeast |
Human IgG receptor FcRn large subunit p51 (FCGRT) |
1-CSB-MP008545HU |
Cusabio |
-
EUR 293.00
-
EUR 963.00
-
EUR 409.00
-
EUR 717.00
|
|
|
Description: Recombinant Human IgG receptor FcRn large subunit p51(FCGRT),partial expressed in Mammalian cell |
Human IgG receptor FcRn large subunit p51 (FCGRT) |
1-CSB-EP008545HU |
Cusabio |
-
EUR 380.00
-
EUR 214.00
-
EUR 1309.00
-
EUR 560.00
-
EUR 873.00
-
EUR 262.00
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Human IgG receptor FcRn large subunit p51(FCGRT),partial expressed in E.coli |
IgG receptor FcRn large subunit p51 Polyclonal Antibody |
42167-100ul |
SAB |
100ul |
EUR 333 |
Macaca fascicularis IgG receptor FcRn large subunit p51 (FCGRT) |
1-CSB-MP851443MOV |
Cusabio |
-
EUR 293.00
-
EUR 963.00
-
EUR 409.00
-
EUR 717.00
|
|
|
Description: Recombinant Macaca fascicularis IgG receptor FcRn large subunit p51(FCGRT),partial expressed in Mammalian cell |
Macaca fascicularis IgG receptor FcRn large subunit p51 (FCGRT) |
1-CSB-EP851443MOV |
Cusabio |
-
EUR 611.00
-
EUR 309.00
-
EUR 1827.00
-
EUR 939.00
-
EUR 1218.00
-
EUR 397.00
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Macaca fascicularis IgG receptor FcRn large subunit p51(FCGRT),partial expressed in E.coli |
IgG receptor FcRn large subunit p51 Polyclonal Conjugated Antibody |
C42167 |
SAB |
100ul |
EUR 397 |
Recombinant (HEK) Human FcRn/b2M Protein (FCGRT/FcRn 1-297aa+B2M 1-119aa heterodimer protein, >95%, his-tag, ~44 kda, low endotoxins) |
FCRN15-R-25 |
Alpha Diagnostics |
25 ug |
EUR 347 |
Recombinant (HEK) Mouse FcRn/b2M Protein (FCGRT/FcRn 1-297aa+B2M 1-119aa heterodimer protein, >95%, his-tag, ~44 kda, low endotoxins) |
FCRN16-R-25 |
Alpha Diagnostics |
25 ug |
EUR 347 |
Human IgG receptor FcRn large subunit p51(FCGRT) ELISA kit |
CSB-EL008545HU-24T |
Cusabio |
1 plate of 24 wells |
EUR 165 |
|
Description: Quantitativesandwich ELISA kit for measuring Human IgG receptor FcRn large subunit p51 (FCGRT) in samples from serum, plasma, tissue homogenates. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price. |
Human IgG receptor FcRn large subunit p51(FCGRT) ELISA kit |
1-CSB-EL008545HU |
Cusabio |
-
EUR 703.00
-
EUR 4843.00
-
EUR 2570.00
|
- 1 plate of 96 wells
- 10 plates of 96 wells each
- 5 plates of 96 wells each
|
|
Description: Quantitativesandwich ELISA kit for measuring Human IgG receptor FcRn large subunit p51(FCGRT) in samples from serum, plasma, tissue homogenates. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits. |
Mouse IgG receptor FcRn large subunit p51(FCGRT) ELISA kit |
CSB-EL008545MO-24T |
Cusabio |
1 plate of 24 wells |
EUR 165 |
|
Description: Quantitativesandwich ELISA kit for measuring Mouse IgG receptor FcRn large subunit p51 (FCGRT) in samples from serum, plasma, tissue homogenates. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price. |
Mouse IgG receptor FcRn large subunit p51(FCGRT) ELISA kit |
1-CSB-EL008545MO |
Cusabio |
-
EUR 703.00
-
EUR 4843.00
-
EUR 2570.00
|
- 1 plate of 96 wells
- 10 plates of 96 wells each
- 5 plates of 96 wells each
|
|
Description: Quantitativesandwich ELISA kit for measuring Mouse IgG receptor FcRn large subunit p51(FCGRT) in samples from serum, plasma, tissue homogenates. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits. |
Human FCGRT/ IgG receptor FcRn large subunit p51 ELISA Kit |
E0881Hu |
Sunlong |
1 Kit |
EUR 605 |
Mouse Fcgrt/ IgG receptor FcRn large subunit p51 ELISA Kit |
E0520Mo |
Sunlong |
1 Kit |
EUR 632 |
Human IgG Receptor FcRn Large Subunit P51 (FCGRT) ELISA Kit |
abx516637-96tests |
Abbexa |
96 tests |
EUR 668 |
|
Mouse IgG Receptor FcRn Large Subunit P51 (FCGRT) ELISA Kit |
abx516638-96tests |
Abbexa |
96 tests |
EUR 739 |
|
Rat IgG Receptor FcRn Large Subunit P51 (FCGRT) ELISA Kit |
abx516639-96tests |
Abbexa |
96 tests |
EUR 739 |
|
ELISA kit for Mouse IgG receptor FcRn large subunit p51 |
EK3291 |
SAB |
96 tests |
EUR 670 |
Description: Enzyme-linked immunosorbent assay kit for quantification of Mouse IgG receptor FcRn large subunit p51 in samples from serum, plasma, tissue homogenates and other biological fluids. |
ELISA kit for Human IgG receptor FcRn large subunit p51 |
EK3292 |
SAB |
96 tests |
EUR 553 |
Description: Enzyme-linked immunosorbent assay kit for quantification of Human IgG receptor FcRn large subunit p51 in samples from serum, plasma, tissue homogenates and other biological fluids. |
Human FCGRT(IgG receptor FcRn large subunit p51) ELISA Kit |
EH1539 |
FN Test |
96T |
EUR 567.6 |
|
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Homo sapiens;Sensitivity: 0.188 ng/ml |
Mouse IgG receptor FcRn large subunit p51, Fcgrt ELISA KIT |
ELI-43963m |
Lifescience Market |
96 Tests |
EUR 865 |
Human IgG receptor FcRn large subunit p51, FCGRT ELISA KIT |
ELI-48499h |
Lifescience Market |
96 Tests |
EUR 824 |
Rat IgG receptor FcRn large subunit p51, Fcgrt ELISA KIT |
ELI-07766r |
Lifescience Market |
96 Tests |
EUR 886 |
Mouse Anti-Rat FcRn heavy chain heterodimers Monoclonal antibody, clone 2G3 |
CABT-L4306-1mg |
Creative Diagnostics |
1 mg |
EUR 897 |
Mouse Anti-Rat FcRn heavy chain heterodimers Monoclonal antibody, clone 2G3 |
CABT-L4306-5mg |
Creative Diagnostics |
5 mg |
EUR 2405 |
Mouse Anti-Rat FcRn heavy chain heterodimers Monoclonal antibody, clone 1G3 |
CABT-L4482-1mg |
Creative Diagnostics |
1 mg |
EUR 897 |
Mouse Anti-Rat FcRn heavy chain heterodimers Monoclonal antibody, clone 1G3 |
CABT-L4482-5mg |
Creative Diagnostics |
5 mg |
EUR 2405 |
Fcgrt ELISA Kit| Rat IgG receptor FcRn large subunit p51 ELISA |
EF018679 |
Lifescience Market |
96 Tests |
EUR 689 |
Fcgrt ELISA Kit| Mouse IgG receptor FcRn large subunit p51 ELIS |
EF014895 |
Lifescience Market |
96 Tests |
EUR 689 |
Recombinant Human IgG receptor FcRn large subunit p51 Protein, GST, E.coli-100ug |
QP6030-ec-100ug |
EnQuireBio |
100ug |
EUR 408 |
Recombinant Human IgG receptor FcRn large subunit p51 Protein, GST, E.coli-10ug |
QP6030-ec-10ug |
EnQuireBio |
10ug |
EUR 200 |
Recombinant Human IgG receptor FcRn large subunit p51 Protein, GST, E.coli-1mg |
QP6030-ec-1mg |
EnQuireBio |
1mg |
EUR 1632 |
Recombinant Human IgG receptor FcRn large subunit p51 Protein, GST, E.coli-200ug |
QP6030-ec-200ug |
EnQuireBio |
200ug |
EUR 634 |
Recombinant Human IgG receptor FcRn large subunit p51 Protein, GST, E.coli-500ug |
QP6030-ec-500ug |
EnQuireBio |
500ug |
EUR 1060 |
Recombinant Human IgG receptor FcRn large subunit p51 Protein, GST, E.coli-50ug |
QP6030-ec-50ug |
EnQuireBio |
50ug |
EUR 263 |
Recombinant Human IgG receptor FcRn large subunit p51 Protein, His, Mammal-100ug |
QP6030-ma-100ug |
EnQuireBio |
100ug |
EUR 1178 |
Recombinant Human IgG receptor FcRn large subunit p51 Protein, His, Mammal-20ug |
QP6030-ma-20ug |
EnQuireBio |
20ug |
EUR 462 |
Recombinant Human IgG receptor FcRn large subunit p51 Protein, His, Mammal-50ug |
QP6030-ma-50ug |
EnQuireBio |
50ug |
EUR 862 |
Recombinant Human IgG receptor FcRn large subunit p51 Protein, His, Yeast-100ug |
QP6030-ye-100ug |
EnQuireBio |
100ug |
EUR 480 |
Recombinant Human IgG receptor FcRn large subunit p51 Protein, His, Yeast-10ug |
QP6030-ye-10ug |
EnQuireBio |
10ug |
EUR 236 |
Recombinant Human IgG receptor FcRn large subunit p51 Protein, His, Yeast-1mg |
QP6030-ye-1mg |
EnQuireBio |
1mg |
EUR 1885 |
Recombinant Human IgG receptor FcRn large subunit p51 Protein, His, Yeast-200ug |
QP6030-ye-200ug |
EnQuireBio |
200ug |
EUR 744 |
Recombinant Human IgG receptor FcRn large subunit p51 Protein, His, Yeast-500ug |
QP6030-ye-500ug |
EnQuireBio |
500ug |
EUR 1206 |
Recombinant Human IgG receptor FcRn large subunit p51 Protein, His, Yeast-50ug |
QP6030-ye-50ug |
EnQuireBio |
50ug |
EUR 299 |
Recombinant FcRn Heterodimer Protein (Ala 23-Ser 298 (FCGRT) & Ile 21-Met 119 (B2M)) |
VAng-1533Lsx-200g |
Creative Biolabs |
200 µg |
EUR 3844 |
Description: Biotinylated Rat FCGRT&B2M Heterodimer Protein is expressed in HEK 293 cells. (Uniprot ID: NP_203502 (FcRN) & NP_036644 (B2M)) |
Recombinant FcRn Heterodimer Protein (Ala 23-Ser 298 (FCGRT) & Ile 21-Met 119 (B2M)) |
VAng-1533Lsx-25g |
Creative Biolabs |
25 µg |
EUR 1013 |
Description: Biotinylated Rat FCGRT&B2M Heterodimer Protein is expressed in HEK 293 cells. (Uniprot ID: NP_203502 (FcRN) & NP_036644 (B2M)) |
Recombinant FcRn Heterodimer Protein (Ala 24-Pro 298 (FCGRT) & Ile 21-Leu 118 (B2M)) |
VAng-1535Lsx-200g |
Creative Biolabs |
200 µg |
EUR 3844 |
Description: Biotinylated Bovine FCGRT&B2M Heterodimer Protein is expressed in HEK 293 cells. (Uniprot ID: Q3T119-1 (FCGRT) & P01888-1 (B2M)) |
Recombinant FcRn Heterodimer Protein (Ala 24-Pro 298 (FCGRT) & Ile 21-Leu 118 (B2M)) |
VAng-1535Lsx-25g |
Creative Biolabs |
25 µg |
EUR 1013 |
Description: Biotinylated Bovine FCGRT&B2M Heterodimer Protein is expressed in HEK 293 cells. (Uniprot ID: Q3T119-1 (FCGRT) & P01888-1 (B2M)) |
Recombinant FcRn Heterodimer Protein (Ser 22-Ser 297 (FCGRT) & Ile 21-Met 119 (B2M)) |
VAng-1546Lsx-200g |
Creative Biolabs |
200 µg |
EUR 3844 |
Description: Biotinylated Mouse FCGRT&B2M Heterodimer Protein is expressed in HEK 293 cells. (Uniprot ID: Q61559 (FCGRT) & P01887 (B2M)) |
Recombinant FcRn Heterodimer Protein (Ser 22-Ser 297 (FCGRT) & Ile 21-Met 119 (B2M)) |
VAng-1546Lsx-25g |
Creative Biolabs |
25 µg |
EUR 1013 |
Description: Biotinylated Mouse FCGRT&B2M Heterodimer Protein is expressed in HEK 293 cells. (Uniprot ID: Q61559 (FCGRT) & P01887 (B2M)) |
Human FcRn Heterodimer Protein (Ala 24-Ser 297 (FCGRT) & Ile 21-Met 119 (B2M)) [His] |
VAng-1538Lsx-1mg |
Creative Biolabs |
1 mg |
EUR 6649 |
Description: Human FCGRT&B2M Heterodimer Protein, His tag, is expressed in HEK 293 cells. (Uniprot ID: P55899-1 (FCGRT) & P61769-1 (B2M)) |
Human FcRn Heterodimer Protein (Ala 24-Ser 297 (FCGRT) & Ile 21-Met 119 (B2M)) [His] |
VAng-1538Lsx-50g |
Creative Biolabs |
50 µg |
EUR 1013 |
Description: Human FCGRT&B2M Heterodimer Protein, His tag, is expressed in HEK 293 cells. (Uniprot ID: P55899-1 (FCGRT) & P61769-1 (B2M)) |
Recombinant FcRn Heterodimer Protein (Ser 22-Ser 297 (FCGRT) & Ile 21-Met 119 (B2M)) [His] |
VAng-1547Lsx-1mg |
Creative Biolabs |
1 mg |
EUR 6649 |
Description: Mouse FCGRT&B2M Heterodimer Protein, His tag, is expressed in HEK 293 cells. (Uniprot ID: Q61559-1 (FCGRT) & P01887-1 (B2M)) |
Recombinant FcRn Heterodimer Protein (Ser 22-Ser 297 (FCGRT) & Ile 21-Met 119 (B2M)) [His] |
VAng-1547Lsx-50g |
Creative Biolabs |
50 µg |
EUR 1013 |
Description: Mouse FCGRT&B2M Heterodimer Protein, His tag, is expressed in HEK 293 cells. (Uniprot ID: Q61559-1 (FCGRT) & P01887-1 (B2M)) |
Recombinant FcRn Heterodimer Protein (Ala 23-Ser 298 (FCGRT) & Ile 21-Met 119 (B2M)) [His] [Strep] |
VAng-1534Lsx-1mg |
Creative Biolabs |
1 mg |
EUR 6649 |
Description: Rat FCGRT&B2M Heterodimer Protein, His tag and Strep tag, is expressed in HEK 293 cells. (Uniprot ID: NP_203502 (FcRN) & NP_036644 (B2M)) |
Recombinant FcRn Heterodimer Protein (Ala 23-Ser 298 (FCGRT) & Ile 21-Met 119 (B2M)) [His] [Strep] |
VAng-1534Lsx-50g |
Creative Biolabs |
50 µg |
EUR 1013 |
Description: Rat FCGRT&B2M Heterodimer Protein, His tag and Strep tag, is expressed in HEK 293 cells. (Uniprot ID: NP_203502 (FcRN) & NP_036644 (B2M)) |
Recombinant FcRn Heterodimer Protein (Ala 24-Ser 297 (FCGRT) & Ile 21-Met 118 (B2M)) [His] [Avi] |
VAng-1536Lsx-200g |
Creative Biolabs |
200 µg |
EUR 3844 |
Description: Biotinylated Feline FCGRT&B2M Heterodimer Protein, His tag and Avi tag, is expressed in HEK 293 cells. (Uniprot ID: W5VRL5-1 (FCGRT) & Q5MGS7-1 (B2M)) |
Recombinant FcRn Heterodimer Protein (Ala 24-Ser 297 (FCGRT) & Ile 21-Met 118 (B2M)) [His] [Avi] |
VAng-1536Lsx-25g |
Creative Biolabs |
25 µg |
EUR 1013 |
Description: Biotinylated Feline FCGRT&B2M Heterodimer Protein, His tag and Avi tag, is expressed in HEK 293 cells. (Uniprot ID: W5VRL5-1 (FCGRT) & Q5MGS7-1 (B2M)) |
Recombinant FcRn Heterodimer Protein (Ala 24-Ser 297 (FCGRT) & Ile 21-Met 119 (B2M)) [His] [Avi] |
VAng-1539Lsx-200g |
Creative Biolabs |
200 µg |
EUR 3844 |
Description: Biotinylated Cynomolgus / Rhesus macaque FCGRT&B2M Heterodimer Protein, His tag and Avi tag, is expressed in HEK 293 cells. (Uniprot ID: Q8SPV9-1 (FCGRT) & Q8SPW0-1 (B2M)) |
Recombinant FcRn Heterodimer Protein (Ala 24-Ser 297 (FCGRT) & Ile 21-Met 119 (B2M)) [His] [Avi] |
VAng-1539Lsx-25g |
Creative Biolabs |
25 µg |
EUR 1013 |
Description: Biotinylated Cynomolgus / Rhesus macaque FCGRT&B2M Heterodimer Protein, His tag and Avi tag, is expressed in HEK 293 cells. (Uniprot ID: Q8SPV9-1 (FCGRT) & Q8SPW0-1 (B2M)) |
Recombinant FcRn Heterodimer Protein (Asp 16-Ser 289 (FCGRT) & Val 21-His 118 (B2M)) [His] [Strep] |
VAng-1545Lsx-1mg |
Creative Biolabs |
1 mg |
EUR 6649 |
Description: Porcine FCGRT&B2M Heterodimer Protein, His tag and Strep tag, is expressed in HEK 293 cells. (Uniprot ID: Q6XAV9 (FCGRT) & Q07717 (B2M)) |
Recombinant FcRn Heterodimer Protein (Asp 16-Ser 289 (FCGRT) & Val 21-His 118 (B2M)) [His] [Strep] |
VAng-1545Lsx-50g |
Creative Biolabs |
50 µg |
EUR 916 |
Description: Porcine FCGRT&B2M Heterodimer Protein, His tag and Strep tag, is expressed in HEK 293 cells. (Uniprot ID: Q6XAV9 (FCGRT) & Q07717 (B2M)) |
Recombinant FcRn Heterodimer Protein (Ser 22-Ser 297 (FCGRT) & Ile 21-Met 119 (B2M)) [His] [Avi] |
VAng-1548Lsx-200g |
Creative Biolabs |
200 µg |
EUR 3844 |
Description: Biotinylated Mouse FCGRT&B2M Heterodimer Protein, His tag and Avi tag, is expressed in HEK 293 cells. (Uniprot ID: Q61559-1 (FCGRT) & P01887-1 (B2M)) |
Recombinant FcRn Heterodimer Protein (Ser 22-Ser 297 (FCGRT) & Ile 21-Met 119 (B2M)) [His] [Avi] |
VAng-1548Lsx-25g |
Creative Biolabs |
25 µg |
EUR 1013 |
Description: Biotinylated Mouse FCGRT&B2M Heterodimer Protein, His tag and Avi tag, is expressed in HEK 293 cells. (Uniprot ID: Q61559-1 (FCGRT) & P01887-1 (B2M)) |
Recombinant FcRn Heterodimer Protein (Ser 22-Ser 297 (FCGRT) & Ile 21-Met 119 (B2M)) [His] [Strep] |
VAng-1549Lsx-1mg |
Creative Biolabs |
1 mg |
EUR 6649 |
Description: Mouse FCGRT&B2M Heterodimer Protein, His tag and Atrep tag, is expressed in HEK 293 cells. (Uniprot ID: Q61559 (FCGRT) & P01887 (B2M)) |
Recombinant FcRn Heterodimer Protein (Ser 22-Ser 297 (FCGRT) & Ile 21-Met 119 (B2M)) [His] [Strep] |
VAng-1549Lsx-50g |
Creative Biolabs |
50 µg |
EUR 1013 |
Description: Mouse FCGRT&B2M Heterodimer Protein, His tag and Atrep tag, is expressed in HEK 293 cells. (Uniprot ID: Q61559 (FCGRT) & P01887 (B2M)) |
Cynomolgus / Rhesus macaque FcRn Heterodimer Protein (Ala 24-Ser 297 (FCGRT) & Ile 21-Met 119 (B2M)) [His] |
VAng-1537Lsx-1mg |
Creative Biolabs |
1 mg |
EUR 6649 |
Description: Cynomolgus / Rhesus macaque FCGRT&B2M Heterodimer Protein, His tag, is expressed in HEK 293 cells. (Uniprot ID: Q8SPV9-1 (FCGRT) & Q8SPW0-1 (B2M)) |
Cynomolgus / Rhesus macaque FcRn Heterodimer Protein (Ala 24-Ser 297 (FCGRT) & Ile 21-Met 119 (B2M)) [His] |
VAng-1537Lsx-50g |
Creative Biolabs |
50 µg |
EUR 1013 |
Description: Cynomolgus / Rhesus macaque FCGRT&B2M Heterodimer Protein, His tag, is expressed in HEK 293 cells. (Uniprot ID: Q8SPV9-1 (FCGRT) & Q8SPW0-1 (B2M)) |
Human FcRn Heterodimer Protein (Ala 24-Ser 297 (FCGRT) & Ile 21-Met 119 (B2M)) [His] [Strep II] |
VAng-1544Lsx-1mg |
Creative Biolabs |
1 mg |
EUR 6649 |
Description: Human FCGRT&B2M Heterodimer Protein, His tag and Strep II tag, is expressed in HEK 293 cells. (Uniprot ID: NP_001129491.1 (FCGRT) & AAH32589 (B2M)) |
Human FcRn Heterodimer Protein (Ala 24-Ser 297 (FCGRT) & Ile 21-Met 119 (B2M)) [His] [Strep II] |
VAng-1544Lsx-50g |
Creative Biolabs |
50 µg |
EUR 1013 |
Description: Human FCGRT&B2M Heterodimer Protein, His tag and Strep II tag, is expressed in HEK 293 cells. (Uniprot ID: NP_001129491.1 (FCGRT) & AAH32589 (B2M)) |
Biotinylated Human FcRn Heterodimer Protein (Ala 24-Ser 297 (FCGRT) & Ile 21-Met 119 (B2M)) [His] [Strep II] |
VAng-1542Lsx-200g |
Creative Biolabs |
200 µg |
EUR 3844 |
Description: Biotinylated Human FCGRT&B2M Heterodimer Protein, His tag and Strep II tag, is expressed in HEK 293 cells. (Uniprot ID: NP_001129491.1 (FCGRT) & AAH32589 (B2M)) |
Biotinylated Human FcRn Heterodimer Protein (Ala 24-Ser 297 (FCGRT) & Ile 21-Met 119 (B2M)) [His] [Strep II] |
VAng-1542Lsx-25g |
Creative Biolabs |
25 µg |
EUR 1013 |
Description: Biotinylated Human FCGRT&B2M Heterodimer Protein, His tag and Strep II tag, is expressed in HEK 293 cells. (Uniprot ID: NP_001129491.1 (FCGRT) & AAH32589 (B2M)) |
Biotinylated Human FcRn Heterodimer Protein (Ala 24-Ser 297 (FCGRT) & Ile 21-Met 119 (B2M)) [His] [Avi] [Strep II] |
VAng-1541Lsx-200g |
Creative Biolabs |
200 µg |
EUR 3844 |
Description: Biotinylated Human FCGRT&B2M Heterodimer Protein, His tag, Avi tag and Strep II tag, is expressed in HEK 293 cells. (Uniprot ID: P55899-1 (FCGRT) & P61769-1 (B2M)) |
Biotinylated Human FcRn Heterodimer Protein (Ala 24-Ser 297 (FCGRT) & Ile 21-Met 119 (B2M)) [His] [Avi] [Strep II] |
VAng-1541Lsx-25g |
Creative Biolabs |
25 µg |
EUR 1013 |
Description: Biotinylated Human FCGRT&B2M Heterodimer Protein, His tag, Avi tag and Strep II tag, is expressed in HEK 293 cells. (Uniprot ID: P55899-1 (FCGRT) & P61769-1 (B2M)) |
Cynomolgus / Rhesus macaque FcRn Heterodimer Protein (Ala 24-Ser 297 (FCGRT) & Ile 21-Met 119 (B2M)) [His] [Strep II] |
VAng-1543Lsx-1mg |
Creative Biolabs |
1 mg |
EUR 6649 |
Description: Cynomolgus / Rhesus macaque FCGRT&B2M Heterodimer Protein, His tag and Strep II tag, is expressed in HEK 293 cells. (Uniprot ID: Q8SPV9-1 (FCGRT) & Q8SPW0-1 (B2M)) |
Cynomolgus / Rhesus macaque FcRn Heterodimer Protein (Ala 24-Ser 297 (FCGRT) & Ile 21-Met 119 (B2M)) [His] [Strep II] |
VAng-1543Lsx-50g |
Creative Biolabs |
50 µg |
EUR 1013 |
Description: Cynomolgus / Rhesus macaque FCGRT&B2M Heterodimer Protein, His tag and Strep II tag, is expressed in HEK 293 cells. (Uniprot ID: Q8SPV9-1 (FCGRT) & Q8SPW0-1 (B2M)) |
Biotinylated Cynomolgus / Rhesus macaque FcRn Heterodimer Protein (Ala 24-Ser 297 (FCGRT) & Ile 21-Met 119 (B2M)) [His] [Avi] [Strep II] |
VAng-1540Lsx-200g |
Creative Biolabs |
200 µg |
EUR 3844 |
Description: Biotinylated Cynomolgus / Rhesus macaque FCGRT&B2M Heterodimer Protein, His tag, Avi tag and Strep II tag, is expressed in HEK 293 cells. (Uniprot ID: Q8SPV9 (FCGRT) & Q8SPW0 (B2M)) |
Biotinylated Cynomolgus / Rhesus macaque FcRn Heterodimer Protein (Ala 24-Ser 297 (FCGRT) & Ile 21-Met 119 (B2M)) [His] [Avi] [Strep II] |
VAng-1540Lsx-25g |
Creative Biolabs |
25 µg |
EUR 1013 |
Description: Biotinylated Cynomolgus / Rhesus macaque FCGRT&B2M Heterodimer Protein, His tag, Avi tag and Strep II tag, is expressed in HEK 293 cells. (Uniprot ID: Q8SPV9 (FCGRT) & Q8SPW0 (B2M)) |
The “Four-Anti and Two-Balance” strategy effectively increased cure rate and reduced mortality. Early antiviral treatment could alleviate disease severity and prevent illness progression, and we found lopinavir/ritonavir combined with abidol showed antiviral effects in COVID-19. Shock and hypoxemia were usually caused by cytokine storms. The artificial liver blood purification system could rapidly remove inflammatory mediators and block cytokine storm.Moreover, it also favored the balance of fluid, electrolyte and acid-base and thus improved treatment efficacy in critical illness. For cases of severe illness, early and also short period of moderate glucocorticoid was supported. Patients with oxygenation index below 200 mmHg should be transferred to intensive medical center.
Conservative oxygen therapy was preferred and noninvasive ventilation was not recommended. Patients with mechanical ventilation should be strictly supervised with cluster ventilator-associated pneumonia prevention strategies. Antimicrobial prophylaxis was not recommended except for patients with long course of disease, repeated fever and elevated procalcitonin (PCT), meanwhile secondary fungal infection should be concerned.Some patients with COVID-19 showed intestinal microbial dysbiosis with decreased probiotics such as Lactobacillus and Bifidobacterium, so nutritional and gastrointestinal function should be assessed for all patients.Nutritional support and application of prebiotics or probiotics were suggested to regulate the balance of intestinal microbiota and reduce the risk of secondary infection due to bacterial translocation. Anxiety and fear were common in patients with COVID-19.
Therefore,we established dynamic assessment and warning for psychological crisis. We also integrated Chinese medicine in treatment to promote disease rehabilitation through classification methods of traditional Chinese medicine. We optimized nursing process for severe patients to promote their rehabilitation. It remained unclear about viral clearance pattern after the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
Therefore, two weeks’ quarantine for discharged patients was required and a regular following up was also needed.The Zhejiang experience and suggestions have been implemented in our center and achieved good results. However, since COVID-19 was a newly emerging disease, more work was warranted to improve strategies of prevention, diagnosis and treatment for COVID-19.